These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 34949112

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effectiveness and value of belimumab and voclosporin for lupus nephritis.
    Tice JA, Mandrik O, Thokala P, Fotheringham J, Pearson SD.
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1495-1499. PubMed ID: 34595943
    [Abstract] [Full Text] [Related]

  • 3. The effectiveness and value of aducanumab for Alzheimer's disease.
    Synnott PG, Whittington MD, Lin GA, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2021 Nov; 27(11):1613-1617. PubMed ID: 34714106
    [Abstract] [Full Text] [Related]

  • 4. The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors.
    Agboola F, Rind DM, Walton SM, Herron-Smith S, Quach D, Pearson SD.
    J Manag Care Spec Pharm; 2021 May; 27(5):667-673. PubMed ID: 33908280
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder.
    Tice JA, Whittington MD, Campbell JD, Pearson SD.
    J Manag Care Spec Pharm; 2021 Apr; 27(4):528-532. PubMed ID: 33769860
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
    Bloudek LM, Pandey R, Fazioli K, Ollendorf DA, Carlson JJ.
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1046-1055. PubMed ID: 34337994
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.
    Nikitin D, Makam AN, Suh K, McKenna A, Carlson JJ, Richardson M, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2023 Feb; 29(2):216-221. PubMed ID: 36705279
    [Abstract] [Full Text] [Related]

  • 12. The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis.
    Pandey R, Ollendorf DA, Fazioli K, Bloudek L, Carlson JJ, Pearson SD.
    J Manag Care Spec Pharm; 2021 Mar; 27(3):405-410. PubMed ID: 33645245
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Effectiveness and Value of Oral Semaglutide for Type 2 Diabetes Mellitus.
    Fazioli KT, Rind DM, Guzauskas GF, Hansen RN, Pearson SD.
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1072-1076. PubMed ID: 32857658
    [Abstract] [Full Text] [Related]

  • 15. Oral treatments for outpatient COVID-19: Effectiveness and value.
    Beinfeld M, Yeung K, Whittington MD, Mohammed R, Nhan E, Pearson SD.
    J Manag Care Spec Pharm; 2022 Aug; 28(8):903-909. PubMed ID: 35876296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effectiveness and value of novel treatments for cystic fibrosis.
    Tice JA, Kuntz KM, Wherry K, Seidner M, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2021 Feb; 27(2):276-280. PubMed ID: 33506736
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.
    Tice JA, Walton SM, Sarker J, Moradi A, Chu JN, Herce-Hagiwara B, Fahim SM, Agboola F, Rind D, Pearson SD.
    J Manag Care Spec Pharm; 2023 May; 29(5):576-581. PubMed ID: 37121251
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.
    Guzauskas GF, Rind DM, Fazioli K, Chapman RH, Pearson SD, Hansen RN.
    J Manag Care Spec Pharm; 2021 Apr; 27(4):455-468. PubMed ID: 33769850
    [Abstract] [Full Text] [Related]

  • 20. The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular Dystrophy.
    Agboola F, Lin GA, Fluetsch N, Walton SM, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2020 Apr; 26(4):361-366. PubMed ID: 32223597
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.